Wolf Popper LLP Announces Investigation on Behalf of BillionToOne, Inc. Investors
Globe Newswire•19/11/2026•15:42 ET
2
Key Highlights
- ➤BillionToOne (BLLN) fell $5.96 to $91.54 after short-seller allegations
- ➤Fuzzy Panda Research alleged undisclosed Tennessee Medicaid-fraud investigation
- ➤Report alleged unnecessary pregnancy-test billing and deductible reductions
- ➤Report alleged doctor overpayments and free phlebotomists for unrelated work
NEW YORK, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of BillionToOne, Inc. (BillionToONe) common stock (NASDAQ: BLLN).
BillionToOne provides genetic testing and recently held its initial public offering on November 5 2025 at $60.00 per share.
Get started
Create a free account to read the full story.
